Alzheon's Seed Round

Alzheon raised a round of funding on October 23, 2013.

Alzheon is a clinical-stage biotechnology company focused on developing therapeutic platforms for both disease modification and symptomatic relief of Alzheimer's disease. The company is developing dru…

Articles about Alzheon's Seed Round: